| Title : Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers - Yang_2017_Chest_151_555 |
| Author(s) : Yang L , Cheriyan J , Gutterman DD , Mayer RJ , Ament Z , Griffin JL , Lazaar AL , Newby DE , Tal-Singer R , Wilkinson IB |
| Ref : Chest , 151 :555 , 2017 |
| Abstract : |
| PubMedSearch : Yang_2017_Chest_151_555 |
| PubMedID: 27884766 |
| Title : Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase - Belyanskaya_2017_Chembiochem_18_837 |
| Author(s) : Belyanskaya SL , Ding Y , Callahan JF , Lazaar AL , Israel DI |
| Ref : Chembiochem , 18 :837 , 2017 |
| Abstract : |
| PubMedSearch : Belyanskaya_2017_Chembiochem_18_837 |
| PubMedID: 28281333 |
| Title : Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor - Lazaar_2016_Br.J.Clin.Pharmacol_81_971 |
| Author(s) : Lazaar AL , Yang L , Boardley RL , Goyal NS , Robertson J , Baldwin SJ , Newby DE , Wilkinson IB , Tal-Singer R , Mayer RJ , Cheriyan J |
| Ref : British Journal of Clinical Pharmacology , 81 :971 , 2016 |
| Abstract : |
| PubMedSearch : Lazaar_2016_Br.J.Clin.Pharmacol_81_971 |
| PubMedID: 26620151 |